26 January 2012
Nancy Faigen
nancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Ventrus gains on PhIII anal fissures data for diltiazem cream; awaits possible replication of EU study
- US FDA stands firm with new trial arm for EpiCept's Ceplene in AML
- FDA change of mind – to add new arm to trial - sets EpiCept's Ceplene further back
- Clovis' $75M offering follows IPO, as pancreatic cancer candidate could carve out a niche
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
Today
Le Plaza Hotel, Brussels, Belgium
Today
Diplomat Hotel, Prague, Czech Republic
Today
Business Design Centre, London
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
